216 related articles for article (PubMed ID: 32553733)
1. Synkinesis in primary and postparalytic hemifacial spasm: Clinical features and therapeutic outcomes of botulinum toxin A treatment.
Su JH; Yang MN; Teng F; Zhang XL; Pan YG; Hu Y; Xiao LB; Pan LZ; Li LX; Jin LJ
Toxicon; 2020 Sep; 184():122-126. PubMed ID: 32553733
[TBL] [Abstract][Full Text] [Related]
2. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
Winterhoff J; Laskawi R
HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm.
Pandey S; Jain S
Neurol India; 2018; 66(4):1036-1042. PubMed ID: 30038089
[TBL] [Abstract][Full Text] [Related]
5. Complications of botulinum toxin application: differences between hemifacial spasm and post-facial palsy synkinesis.
Cakmak MA; Sahin S; Cinar N; Karsidag S
Acta Neurol Belg; 2014 Dec; 114(4):331. PubMed ID: 24647748
[No Abstract] [Full Text] [Related]
6. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.
Tambasco N; Filidei M; Nigro P; Parnetti L; Simoni S
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941718
[TBL] [Abstract][Full Text] [Related]
7. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
[TBL] [Abstract][Full Text] [Related]
8. [Changes in dose and injection pattern in the botulinum toxin long-term therapy of facial dyskinesis].
Laskawi R; Niemczewska A; Schneider S; Winterhoff J; Beutner C; Rohrbach S
Laryngorhinootologie; 2014 Mar; 93(3):186-92. PubMed ID: 24323508
[TBL] [Abstract][Full Text] [Related]
9. Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport.
Kollewe K; Mohammadi B; Dengler R; Dressler D
J Neural Transm (Vienna); 2010 Jun; 117(6):759-63. PubMed ID: 20437061
[TBL] [Abstract][Full Text] [Related]
10. Buccinator synkinesis treated by botulinum toxin in facial palsy and hemifacial spasms.
Kanerva M
J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1464-1469. PubMed ID: 33358465
[TBL] [Abstract][Full Text] [Related]
11. Platysma synkinesis in facial palsy and botulinum toxin type A.
Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
[TBL] [Abstract][Full Text] [Related]
12. Effect of endoscopic brow lift on contractures and synkinesis of the facial muscles in patients with a regenerated postparalytic facial nerve syndrome.
Bran GM; Börjesson PKE; Boahene KD; Gosepath J; Lohuis PJFM
Plast Reconstr Surg; 2014 Jan; 133(1):121-129. PubMed ID: 24105091
[TBL] [Abstract][Full Text] [Related]
13. Clinical assessment of patients with primary and postparalytic hemifacial spasm: a retrospective study.
Felicio AC; Godeiro-Junior Cde O; Borges V; Silva SM; Ferraz HB
Arq Neuropsiquiatr; 2007 Sep; 65(3B):783-6. PubMed ID: 17952280
[TBL] [Abstract][Full Text] [Related]
14. Subjective and Objective Measures in the Treatment of Hemifacial Spasm With OnabotulinumtoxinA.
Chundury RV; D'Angelo AS; Couch SM; Holds JB
Ophthalmic Plast Reconstr Surg; 2016; 32(2):133-7. PubMed ID: 25811161
[TBL] [Abstract][Full Text] [Related]
15. No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm.
Lorenzano C; Bagnato S; Gilio F; Fabbrini G; Berardelli A
Neurotox Res; 2006 Apr; 9(2-3):141-4. PubMed ID: 16785111
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A is effective to treat tension-type headache caused by hemifacial spasm.
Mizuma A; Nagata E; Yasuda T; Kouchi M; Nakayama T; Honma K; Tokuoka K; Kitagawa Y; Nogawa S; Takizawa S
J Clin Neurosci; 2017 Oct; 44():284-288. PubMed ID: 28734794
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
18. Does needle size matter? Effects of micro-hypodermic needle injections of botulinum toxin type A in patients with hemifacial spasm.
Maytharakcheep S; Phokaewvarangkul O; Bhidayasiri R
Parkinsonism Relat Disord; 2024 Jan; 118():105950. PubMed ID: 38081119
[TBL] [Abstract][Full Text] [Related]
19. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
Schellini SA; Matai O; Igami TZ; Padovani CR; Padovani CP
Arq Bras Oftalmol; 2006; 69(1):23-6. PubMed ID: 16491229
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
